Perceptive-Advisors

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "MRUS",
  "AKRO",
  "NUVL",
  "AXSM",
  "EWTX",
  "CNTA",
  "RGEN",
  "INSM",
  "ARGX",
  "AORT",
  "MDGL",
  "FOLD",
  "ADMA",
  "BSX",
  "MREO",
  null,
  "RCKT",
  "ADPT",
  "ATXS",
  "IMTX",
  "NRIX",
  "ACRV",
  "ADGM",
  "ALDX",
  "AVTX",
  "ATHA",
  "AMLX",
  "JANX",
  "APYX",
  "AVR",
  "APLT",
  null,
  null,
  "CTNM",
  "SYRE",
  "APGE",
  "ISRG",
  null,
  "INBX",
  "NBIX",
  "KALA",
  "LXEO",
  "NAUT",
  null,
  "OKUR",
  null,
  "IOVA",
  "BDSX",
  null,
  "IKT",
  "NBTX",
  null,
  null,
  "PODD",
  "ZYME",
  "RAPT",
  "PTGX",
  "TRAW",
  "SLDB",
  "PRAX",
  "AQST",
  "LYRA",
  "RYTM",
  "SLNO",
  "ACLX",
  "DYN",
  "SCPH",
  null,
  "DCTH",
  "EOLS",
  "EYPT",
  "VRNA",
  "VKTX",
  "VRDN",
  "XENE",
  "OBIO",
  null,
  "IMVT",
  "PCVX",
  "CRGX",
  "CELC",
  "CGEM",
  "DXCM",
  "IRON",
  "MGTX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 86
Total Value: 2694161578
Accession Number: 0001012975-25-000242
Form Type: 13F-HR
CIK: perceptive-advisors
Manager Name: Perceptive-Advisors

Data Enrichment

87% identified

75 identified11 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

86 positions • $2.7B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 4 of 5

Sort by:

Adaptive Biotechnologies Corp

ADPT|00650F109

Shares:931.0K

Value:$6.9M

% of Portfolio:0.3% ($6.9M/$2.7B)

OCULAR THERAPEUTIX, INC

OCUL|67576A100

Shares:915.8K

Value:$6.7M

% of Portfolio:0.2% ($6.7M/$2.7B)

DELCATH SYSTEMS, INC.

DCTH|24661P807

Shares:462.4K

Value:$5.9M

% of Portfolio:0.2% ($5.9M/$2.7B)

RAPT Therapeutics, Inc.

RAPT|75382E109

Shares:4.4M

Value:$5.4M

% of Portfolio:0.2% ($5.4M/$2.7B)

G52441105

Shares:200.0K

Value:$5.0M

% of Portfolio:0.2% ($5.0M/$2.7B)

G4444H101

Shares:398.0K

Value:$4.5M

% of Portfolio:0.2% ($4.5M/$2.7B)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:1.0M

Value:$4.3M

% of Portfolio:0.2% ($4.3M/$2.7B)

67577R102

Shares:4.3M

Value:$4.2M

% of Portfolio:0.2% ($4.2M/$2.7B)

Avalo Therapeutics, Inc.

AVTX|05338F306

Shares:520.0K

Value:$4.2M

% of Portfolio:0.2% ($4.2M/$2.7B)

Nurix Therapeutics, Inc.

NRIX|67080M103

Shares:297.6K

Value:$3.5M

% of Portfolio:0.1% ($3.5M/$2.7B)

Mereo BioPharma Group plc

MREO|589492107

Shares:877.0K

Value:$2.0M

% of Portfolio:0.1% ($2.0M/$2.7B)

Lyra Therapeutics, Inc.

LYRA|55234L105

Shares:12.8M

Value:$1.6M

% of Portfolio:0.1% ($1.6M/$2.7B)

KALA BIO, Inc.

KALA|483119202

Shares:277.6K

Value:$1.6M

% of Portfolio:0.1% ($1.6M/$2.7B)

Athira Pharma, Inc.

ATHA|04746L104

Shares:5.4M

Value:$1.5M

% of Portfolio:0.1% ($1.5M/$2.7B)

BIODESIX INC

BDSX|09075X108

Shares:2.2M

Value:$1.4M

% of Portfolio:0.1% ($1.4M/$2.7B)

scPharmaceuticals Inc.

SCPH|810648105

Shares:500.0K

Value:$1.3M

% of Portfolio:0.0% ($1.3M/$2.7B)

Traws Pharma, Inc.

TRAW|68232V884

Shares:421.8K

Value:$970.1K

% of Portfolio:0.0% ($970.1K/$2.7B)

ROCKET PHARMACEUTICALS, INC.

RCKT|77313F106

Shares:140.7K

Value:$938.6K

% of Portfolio:0.0% ($938.6K/$2.7B)

Cullinan Therapeutics, Inc.

CGEM|230031106

Shares:80.1K

Value:$606.4K

% of Portfolio:0.0% ($606.4K/$2.7B)

Lexeo Therapeutics, Inc.

LXEO|52886X107

Shares:139.8K

Value:$485.2K

% of Portfolio:0.0% ($485.2K/$2.7B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Adaptive Biotechnologies Corp(ADPTcusip00650F109)	931.0K	QoQ NEW(+931.0K) YoY NEW(+931.0K)	All Managers (Combined)	$6.9M	0.3% ($6.9M/$2.7B)	QoQ NEW(+$6.9M) YoY NEW(+$6.9M)
OCULAR THERAPEUTIX, INC(OCULcusip67576A100)	915.8K	QoQ -15.08% (-162.7K) YoY -72.45% (-2.4M)	All Managers (Combined)	$6.7M	0.2% ($6.7M/$2.7B)	QoQ -27.11% (-$2.5M) YoY -77.81% (-$23.5M)
DELCATH SYSTEMS, INC.(DCTHcusip24661P807)	462.4K	QoQ +824.84% (+412.4K) YoY NEW(+462.4K)	All Managers (Combined)	$5.9M	0.2% ($5.9M/$2.7B)	QoQ +877.84% (+$5.3M) YoY NEW(+$5.9M)
RAPT Therapeutics, Inc.(RAPTcusip75382E109)	4.4M	QoQ -24.84% (-1.5M) YoY +261.18% (-3.2M)	All Managers (Combined)	$5.4M	0.2% ($5.4M/$2.7B)	QoQ -41.97% (-$3.9M) YoY -50.93% (-$5.6M)
(cusipG52441105)✕	200.0K	QoQ NEW(+200.0K) YoY NEW(+200.0K)	All Managers (Combined)	$5.0M	0.2% ($5.0M/$2.7B)	QoQ NEW(+$5.0M) YoY NEW(+$5.0M)
(cusipG4444H101)✕	398.0K	QoQ -20.40% (-102.0K) YoY -20.40% (-102.0K)	All Managers (Combined)	$4.5M	0.2% ($4.5M/$2.7B)	QoQ -14.33% (-$752.6K) YoY -13.51% (-$702.6K)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	1.0M	QoQ 0.00% (-0) YoY NEW(+1.0M)	All Managers (Combined)	$4.3M	0.2% ($4.3M/$2.7B)	QoQ -49.99% (-$4.3M) YoY NEW(+$4.3M)
(cusip67577R102)✕	4.3M	QoQ NEW(+4.3M) YoY NEW(+4.3M)	All Managers (Combined)	$4.2M	0.2% ($4.2M/$2.7B)	QoQ NEW(+$4.2M) YoY NEW(+$4.2M)
Avalo Therapeutics, Inc.(AVTXcusip05338F306)	520.0K	QoQ NEW(+520.0K) YoY NEW(+520.0K)	All Managers (Combined)	$4.2M	0.2% ($4.2M/$2.7B)	QoQ NEW(+$4.2M) YoY NEW(+$4.2M)
Nurix Therapeutics, Inc.(NRIXcusip67080M103)	297.6K	QoQ -9.99% (-33.1K) YoY NEW(+297.6K)	All Managers (Combined)	$3.5M	0.1% ($3.5M/$2.7B)	QoQ -43.24% (-$2.7M) YoY NEW(+$3.5M)
Mereo BioPharma Group plc(MREOcusip589492107)	877.0K	QoQ -19.21% (-208.6K) YoY NEW(+877.0K)	All Managers (Combined)	$2.0M	0.1% ($2.0M/$2.7B)	QoQ -48.06% (-$1.8M) YoY NEW(+$2.0M)
Lyra Therapeutics, Inc.(LYRAcusip55234L105)	12.8M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.6M	0.1% ($1.6M/$2.7B)	QoQ -38.83% (-$1.0M) YoY -97.97% (-$77.7M)
KALA BIO, Inc.(KALAcusip483119202)	277.6K	QoQ NEW(+277.6K) YoY NEW(+277.6K)	All Managers (Combined)	$1.6M	0.1% ($1.6M/$2.7B)	QoQ NEW(+$1.6M) YoY NEW(+$1.6M)
Athira Pharma, Inc.(ATHAcusip04746L104)	5.4M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$1.5M	0.1% ($1.5M/$2.7B)	QoQ -51.44% (-$1.6M) YoY -89.60% (-$13.3M)
BIODESIX INC(BDSXcusip09075X108)	2.2M	QoQ 0.00% (-0) YoY NEW(+2.2M)	All Managers (Combined)	$1.4M	0.1% ($1.4M/$2.7B)	QoQ -59.15% (-$2.0M) YoY NEW(+$1.4M)
scPharmaceuticals Inc.(SCPHcusip810648105)	500.0K	QoQ 0.00% (-0) YoY NEW(+500.0K)	All Managers (Combined)	$1.3M	0.0% ($1.3M/$2.7B)	QoQ -25.70% (-$455.0K) YoY NEW(+$1.3M)
Traws Pharma, Inc.(TRAWcusip68232V884)	421.8K	QoQ +156.93% (-257.6K) YoY NEW(+421.8K)	All Managers (Combined)	$970.1K	0.0% ($970.1K/$2.7B)	QoQ -33.45% (-$487.6K) YoY NEW(+$970.1K)
ROCKET PHARMACEUTICALS, INC.(RCKTcusip77313F106)	140.7K	QoQ -62.82% (-237.9K) YoY -92.18% (-1.7M)	All Managers (Combined)	$938.6K	0.0% ($938.6K/$2.7B)	QoQ -80.27% (-$3.8M) YoY -98.06% (-$47.6M)
Cullinan Therapeutics, Inc.(CGEMcusip230031106)	80.1K	QoQ NEW(+80.1K) YoY NEW(+80.1K)	All Managers (Combined)	$606.4K	0.0% ($606.4K/$2.7B)	QoQ NEW(+$606.4K) YoY NEW(+$606.4K)
Lexeo Therapeutics, Inc.(LXEOcusip52886X107)	139.8K	QoQ 0.00% (-0) YoY NEW(+139.8K)	All Managers (Combined)	$485.2K	0.0% ($485.2K/$2.7B)	QoQ -47.26% (-$434.9K) YoY NEW(+$485.2K)